Biotechnology Stocks II Performance Guide: Neurogene Inc. (NGNE)
NGNE has no dividends.
Table and Chart of NGNE Performance
See what a $1,000 investment in NGNE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NGNE Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $177.80 |
| End Date | May-16-2024 |
| End Price | $33.72 |
| # Prices | 121 |
| Min Date | Feb-28-2023 |
| Min Price | $10.07 |
| Max Date | Jan-31-2017 |
| Max Price | $361.20 |
| Total Return | -81.03% |
| Annualized Return | -15.20% |
| Current Value of $1,000 Purchase | $190 |
| Number Returns | 7,260 |
| Average Return | -10.04% |
| Number Profitable Returns | 2,252 |
| Percent Profitable Returns | 31.02% |
| Number Unprofitable Returns | 5,008 |
| Percent Unprofitable Returns | 68.98% |
| Profitable to Unprofitable Returns Ratio | 0.45 |
| NGNE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $406,511,000 |
| Beta | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $53 |
| 52 Week Low | $12.2 |
| Analyst Target Price | $38 |
| 50-Day Moving Average | $19.27 |
| 200-Day Moving Average | $16.34 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | 0% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NGNE Compare Returns with S&P 500
NGNE Trendline Chart
NGNE Moving Average Chart
NGNE Stock Return Map - See Patterns of Gains and Losses
NGNE Stock Returns/Purchase Dates